Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 1
1(50.0%)
2Total
N/A(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03622294Not ApplicableCompleted

A Clinical Analysis of Bella Blankets® Protective Coverlets

Role: collaborator

NCT01750320Phase 1Completed

Koning Breast Computed Tomography Guided Biopsy

Role: collaborator

NCT01107860Completed

Cone Beam Computed Tomography for Breast Imaging

Role: collaborator

All 3 trials loaded